Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer

BACKGROUND: Bisphosphonate therapy has been readily accepted as standard of care for individuals with bone metastases from breast cancer. In this study we determined whether the proportion of patients experiencing a skeletal related event (SRE) in a clinical practice population was similar to that o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liauw, Winston, Segelov, Eva, Lih, Anna, Dunleavy, Ms Ruth, Links, Matthew, Ward, Robyn
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1184064/
https://www.ncbi.nlm.nih.gov/pubmed/16048654
http://dx.doi.org/10.1186/1471-2407-5-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1184064/
https://www.ncbi.nlm.nih.gov/pubmed/16048654
http://dx.doi.org/10.1186/1471-2407-5-89

Ejemplares similares